Abstract
A two-step, biocompatible strategy enables site-specific generation of branched and macrocyclic peptide-protein conjugates. Solvent-exposed cysteines on proteins are modified by a small bifunctional reagent at near-physiological pH, followed by cyanopyridine-aminothiol click reactions to create branched or macrocyclic peptide architectures. This method offers design strategies for next-generation protein therapeutics.
Original language | English |
---|---|
Number of pages | 4 |
Journal | Chemical Communications |
Early online date | Jan 2025 |
DOIs | |
Publication status | Published - 17 Jan 2025 |